Franciscan Missionaries of Our Lady Health System
Questions or Suggestions
Drug Information Questions
Search by name
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
Do Not Crush
REMS
Therapeutic Interchange
Do Not Tube-LALK
Do Not Tube-LACH
Restricted
CMS Self-Administered Drug Exclusion List
Look Alike Sound Alike Drugs
FMOLHS Rhazdrugs
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
News
Boards
*COVID-19 Pharmacy Resources
Franciscan Missionaries of Our Lady Health System
Questions or Suggestions
Drug Information Questions
Search by name
Additional search options
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
Do Not Crush
REMS
Therapeutic Interchange
Do Not Tube-LALK
Do Not Tube-LACH
Restricted
CMS Self-Administered Drug Exclusion List
Look Alike Sound Alike Drugs
FMOLHS Rhazdrugs
Webpage Links
Search results for:
denosumab
denosumab
Brand names:
Prolia, Xgeva
Form
Strength
ANAN
ASMP
LACH
LALK
LOHH
LOLR
LOWC
SDSD
SESE
SFSF
Formulary Status
SOLUTION, SUBCUTANEOUS
60 mg/mL; 120 mg/1.7 mL
restricted
VIEW MORE
Bone Resorption Inhibitors
CLASS
922400
Comments:
Chemotherapy Chart
Last updated:
Jul. 31, 2025
Black Box Warning:
Prolia - Severe Hypocalcemia in Patients with Advanced Kidney Disease and Severe Hypocalcemia and Mineral Metabolism Changes
Restricted:
denosumab (Prolia, Xgeva) is restricted to use in the Outpatient setting
UpToDate
FDA Package Inserts
Acadiana Market Specific P&T Updates
Jackson Market Specific P&T Updates
UpToDate Lexidrug
Chemotherapy Chart